Monday, May 25

Browsing: AdvancedMetastatic

Diagnosis

104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy

By NewsCancerMay 20, 20260

BackgroundPatients with hormone receptor–positive (HR+)/HER2-negative (HER2–) advanced/metastatic breast cancer who have tumors that progressed after CDK4/6 inhibitor (CDK4/6i) and endocrine…

Survivors

TIP103 Randomized Phase 3 Clinical Trial Evaluating Atirmociclib Plus Letrozole Versus a CDK4/6 Inhibitor Plus Letrozole as First-Line Treatment for Patients With HR+/HER2− Advanced/Metastatic Breast Cancer

By NewsCancerMay 20, 20260

BackgroundCDK4/6 inhibitors, in combination with endocrine therapy, have improved survival outcomes when used as first-line treatment for patients with hormone…

Support

TIP113 HERTHENA-PanTumor01 (NCT06172478): Expansion of a Global Phase 2 Trial of HER3-DXd in Patients With Advanced/Metastatic HR+/HER2− Breast Cancer

By NewsCancerMay 14, 20260

BackgroundIncreased tumor expression of HER3, a member of the HER/EGFR family of receptor tyrosine kinases, is associated with poor clinical…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

How I Stopped Feeling Exhausted by Other People’s Needs and Feelings

Beyond the research: 6 ways we’ve turned evidence into impact – Cancer Research UK

Scientists discover hidden liver switch that cuts harmful cholesterol

Browsing: AdvancedMetastatic

104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy

TIP103 Randomized Phase 3 Clinical Trial Evaluating Atirmociclib Plus Letrozole Versus a CDK4/6 Inhibitor Plus Letrozole as First-Line Treatment for Patients With HR+/HER2− Advanced/Metastatic Breast Cancer

TIP113 HERTHENA-PanTumor01 (NCT06172478): Expansion of a Global Phase 2 Trial of HER3-DXd in Patients With Advanced/Metastatic HR+/HER2− Breast Cancer

How I Stopped Feeling Exhausted by Other People’s Needs and Feelings

Beyond the research: 6 ways we’ve turned evidence into impact – Cancer Research UK

Scientists discover hidden liver switch that cuts harmful cholesterol

Scientists supercharge natural killer cells to fight aggressive cancers

How I Stopped Feeling Exhausted by Other People’s Needs and Feelings

Beyond the research: 6 ways we’ve turned evidence into impact – Cancer Research UK

Scientists discover hidden liver switch that cuts harmful cholesterol

Scientists supercharge natural killer cells to fight aggressive cancers

Latest Post

How I Stopped Feeling Exhausted by Other People’s Needs and Feelings

Beyond the research: 6 ways we’ve turned evidence into impact – Cancer Research UK

Scientists discover hidden liver switch that cuts harmful cholesterol

Subscribe to Updates

What's Hot

Browsing: AdvancedMetastatic